Companies: 10,795·Total market cap: $144.5T
BioInvent International AB (publ)

BioInvent International AB (publ)

BOVNFOTCHealthcare● Active
$6.63
+$3.34(+101.61%)
Market Cap$436282920
P/E Ratio—
52W High$6.63
52W Low$3.2886
Overview
股票排行：Biotechnology·Healthcare·查看全部市值排行 →

BioInvent International AB (publ)（BOVNF）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · BOVNF · 截至 Jun 9, 2026

关键指标

EPS (TTM)$-5.11bovnf eps ttm · bovnf earnings per shareEarnings history
PE Ratio (TTM)—bovnf pe ratio ttm · bovnf price to earningsPE Ratio deep dive
Revenue (TTM)$217.8Mbovnf revenue ttm · bovnf annual revenueFull revenue history
Dividend Yield不分红does bovnf pay dividends · bovnf dividend yieldDividend history
Shares Outstanding65.8Mbovnf shares outstanding · bovnf floatShares outstanding history
Next EarningsAug 27, 2026Est.bovnf earnings date · bovnf next earningsEarnings history

探索 BioInvent International AB (publ) 数据

bovnf stock data · financials
市值$436.3Mbovnf market cap · bovnf valuation
分析师预测—
股息不分红does bioinvent international ab (publ) pay dividends · bovnf dividend yield
营收$225.9M+405.59%bioinvent international ab (publ) annual revenue · bovnf revenue
盈利EPS $-5.07+22.36%bovnf earnings · bovnf eps
市盈率—bovnf pe ratio · bovnf price to earnings

财务快照

完整财报
FY 2025Revenue$225.9M▲ +405.59% YoY
202320242025
bioinvent international ab (publ) revenue · bovnf revenue 2025
FY 2025Net Income-$332.0M▲ +22.67% YoY
202320242025
bioinvent international ab (publ) net income · bovnf profit 2025
FY 2025EPS$-5.07▲ +22.36% YoY
202320242025
bovnf eps · bioinvent international ab (publ) earnings per share 2025
TTM:Revenue: $217.8MNet Income: -$334.6MEPS: $-5.11View income statement →

股票表现

完整历史
1D+101.61%
1W+101.52%
1M+101.52%
3M+101.52%
YTD+101.52%
1Y+41.06%
5Y-7.57%

关于 BioInvent International AB (publ)

CEOMartin Welschof
IPO DateSep 3, 2013
Employees114
CountrySE
Websitebioinvent.com

BioInvent International AB (publ) is a clinical-stage biotechnology company primarily focused on identifying, exploring, and engineering immunomodulatory antibodies to combat various forms of cancer. …

BiotechnologyHealthcareOTCSE

what is bioinvent international ab (publ) · bovnf stock overview · bioinvent international ab (publ) company profile · who is bioinvent international ab (publ) ceo · bovnf OTC · bioinvent international ab (publ) headquarters · bioinvent international ab (publ) business segments

关于股票概览与关键数据

BioInvent International AB (publ)（BOVNF）是 Biotechnology 行业的 Healthcare 类公司，于 Sep 3, 2013 在 OTC 上市。截至最近交易日，BOVNF 股价为 $6.63，市值约为 $436.3M。过去12个月累计回报 +41.06%，年初至今回报 +101.52%。

2025 财年 BioInvent International AB (publ) 营收 $225.9M。完整财务数据（营收历史、盈利、资产负债表）请使用上方标签页。

常见问题

截至最近一个交易日，BioInvent International AB (publ)（BOVNF）股价为 $6.63，在 OTC 上市，52周区间为 $3.29 – $6.63。

BOVNF 最新股价BOVNF quote todaylive ticker 实时行情
数据来源：Financial Modeling Prep最后更新：Jun 9, 2026本内容不构成投资建议